Ralph Yarro
About Ralph Yarro
Ralph Yarro Founder and Chairman, Techcyte
Ralph Yarro is the Founder and Chairman of Techcyte, a company known for its innovation in digital diagnostics. Under his leadership, Techcyte has grown to include specialized divisions such as Vetcyte and Sporecyte. Yarro has played a crucial role in shaping the company's strategic direction and expanding its technological capabilities.
Techcyte White Paper Licensed from University of Utah
Ralph Yarro licensed an important white paper on white blood cell classification from the University of Utah. This foundational step was integral to the development of Techcyte's digital diagnostics technology, specifically in the classification of white blood cells.
Fundraising and Initial Seed Funding
Ralph Yarro successfully raised an initial seed funding of $113,000 for Techcyte. This early capital was instrumental in advancing the company's technological developments and research initiatives.
Development of White Blood Cell Classification Prototype
Ralph Yarro was part of the team that developed a prototype for classifying white blood cells. This innovation marked a significant milestone for Techcyte and laid the groundwork for future technological advancements in digital diagnostics.
Strategic Partnerships and Investments
Ralph Yarro played an essential role in establishing strategic partnerships and securing investments. Notable collaborations include those with Motic and ARUP, which have been pivotal in advancing Techcyte's diagnostic technologies and expanding its market reach.
Launch of Techcyte & ARUP's Fecal Ova and Parasite Test
Ralph Yarro contributed to the launch of the fecal Ova and Parasite test developed in collaboration between Techcyte and ARUP. This product represents a significant achievement in enhancing diagnostic accuracy and efficiency.
Techcyte's First Profitable Year
Under the guidance of Ralph Yarro, Techcyte achieved its first profitable year. This milestone is a testament to his effective leadership and strategic vision for the company.
VETSCAN IMAGYST Vet Fecal Testing Launch
Ralph Yarro was involved in the launch of VETSCAN IMAGYST, a veterinary fecal testing product developed in collaboration with Zoetis. This launch broadened Techcyte's impact in the veterinary diagnostics field.
U.S. Patent for Automatic Detection in Microscopy Slides
As part of his contributions to Techcyte, Ralph Yarro was involved in a project that received a U.S. patent for automatic detection of objects in microscopy slides using hidden features and auxiliary ground truth. This patent is an important asset for Techcyte's technological portfolio.
Collaboration with Mayo Clinic for CP Tests and Platforms
Ralph Yarro played a role in Techcyte's strategic collaboration with the Mayo Clinic. This partnership focuses on developing CP tests and platforms, contributing to advancements in medical diagnostics.